Cory Freedland

Principal · Samsara BioCapital

Email

Verified, deliverable email

Unlock Cory and the rest of Samsara BioCapital

One payment, no subscription - every verified contact at Samsara BioCapital drops into your wallet.

Principal at Samsara BioCapital

Stages: Series A, Seed
Sectors: Health tech
Cheque size: €920k–€92M
Freshness: Verified today
Fund size: $310.1M

Notable investments

Alpha-9 OncologySeries C · $180M · 2024
Palvella TherapeuticsSeries C · $45M · 2020
Velicept TherapeuticsSeries B · $15M · 2018

Frequently co-invests with

Elena VibochGeneral CatalystMelissa McCrackenNextech InvestPatrick HeronFrazier Healthcare Partners

Cory Freedland's colleagues at Samsara BioCapital

Every verified colleague at Samsara BioCapital

One payment, no subscription - they all drop into your wallet.

Srini AkkarajuManaging Partner, Samsara BioCapital

Marcos MillaVenture Partner, Samsara BioCapital

Aditya AsokanAssociate, Samsara BioCapital

Mike DybbsPartner, Samsara BioCapital

Abe BassanPrincipal, Samsara BioCapital

See all 6 at Samsara BioCapital →

Related lists

Health tech investors

Similar investors

Quan ZhouManaging Partner, IDG Capital

Raffi KamberGeneral Partner, Singular

Blake PateAnalyst, Bios Partners

Przemek OblojManaging Partner, Blue Horizon

Prashant NarangPartner, Fluid Ventures

Prachi SinhaInvestor, Axilor Ventures

Every contact is a verified, deliverable email. How Mintround verifies contacts.

Are you Cory Freedland? Request removal of this listing.